A ‘tailor made’ vaccine trialled as part of public health response to group B meningococcal epidemic in New Zealand
Holst, J and Aaberge, I and Oster, Philipp and Lennon, D and D Martin and J O'Hallahan and K Nord and H Nøkleby and L M Næss and L M Næss and P Kristiansen and A G Skryten and K Bryn and A Aase and R Rappuoli and E Rosenqvist, Weekly releases (1997–2007), 7, 2262 (2003), https://doi.org/10.2807/esw.07.30.02262-en